EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel BODIPY-Zn Complex as Innovative Sonosensitizer for Enhanced Sonodynamic Therapy

Jungmin Lee, Soeun Lee, Gihoon Jo, Eunbin Hwang, Junhyoung Lee, Jiyou Han iD, Hyo Sung Jung iD

Molecules · 2025

DOI: 10.3390/molecules30071587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jungmin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical & Chemical Sciences, Hyupsung University, Hwasung-si 18330, Republic of Korea. Hauptthemen laut MEDLINE: Boron Compounds, Zinc, Ultrasonic Therapy, Photosensitizing Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ultrasound (US)-based sonodynamic therapy (SDT) presents a promising and secure approach to treating cancer with the advantage of enhanced tissue penetration, making it a favorable option compared with traditional photodynamic therapy. However, the search for innovative sonosensitizers that exhibit both high sonosensitizing efficacy and good biocompatibility poses a formidable challenge. In this research, we prepared a novel BODIPY-Zn complex (BSS-Zn) incorporating a hydrophilic short polyethylene glycol unit and explored its feasibility as a sonosensitizer. BSS-Zn exhibited enhanced reactive oxygen species (ROS) generation behavior upon US irradiation, outperforming a control sensitizer, BSS (an analog lacking the Zn complex), and a commercial sonosensitizer, ZnPc (currently undergoing clinical testing), with regard to sonosensitizing properties. The enhanced effect of BSS-Zn was attributed to increased levels of ROS, such as hydroxyl radicals, singlet oxygen, and superoxide, mediated by US exposure in aqueous media. The SDT effect of BSS-Zn on MDA-MB-231 cells was verified by confirming the intracellular types of generated ROS and evaluating the cytotoxicity to MDA-MB-231 cancer cells. This pioneering study highlights the potential of BSS-Zn as an innovative sonosensitizer for SDT. Our findings provide valuable guidance for the design of efficient sonosensitizers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron CompoundsZincUltrasonic TherapyPhotosensitizing AgentsCoordination ComplexesHumansCell Line, TumorReactive Oxygen SpeciesCell Survival

Stichwörter der Autor:innen

BODIPY-Zn complexreactive oxygen speciessonodynamic therapysonosensitizerultrasound

Substanzen

Boron Compounds4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneZincReactive Oxygen SpeciesPhotosensitizing AgentsCoordination Complexes

Autor:innen und Institutionen

  • Department of Biomedical & Chemical Sciences, Hyupsung University, Hwasung-si 18330, Republic of Korea.
  • Department of Gerontology (AgeTech-Service Convergence Major), Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si 17104, Republic of Korea.

ORCID-Profile: Jiyou Han, Hyo Sung Jung

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, J., Lee, S., Jo, G., Hwang, E., Lee, J., Han, J., & Jung, H. S. (2025). A Novel BODIPY-Zn Complex as Innovative Sonosensitizer for Enhanced Sonodynamic Therapy. Molecules. https://doi.org/10.3390/molecules30071587

Vancouver

Lee J, Lee S, Jo G, Hwang E, Lee J, Han J, et al. A Novel BODIPY-Zn Complex as Innovative Sonosensitizer for Enhanced Sonodynamic Therapy. Molecules. 2025. doi:10.3390/molecules30071587

BibTeX
@article{Lee2025,
  author = {Lee, Jungmin and Lee, Soeun and Jo, Gihoon and Hwang, Eunbin and Lee, Junhyoung and Han, Jiyou and Jung, Hyo Sung},
  title = {A Novel BODIPY-Zn Complex as Innovative Sonosensitizer for Enhanced Sonodynamic Therapy},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30071587}
}
Kostenlos starten →